Foam in pharmaceutical and medical applications

https://doi.org/10.1016/j.cocis.2019.10.007Get rights and content

Highlights

  • Topical foams for cosmetic and dermal applications.

  • Recent assessment methods of important physical parameters of topical foam.

  • Topical foams in contact with skin or skin-like membranes.

Abstract

Topical foams are an attractive and promising delivery system for cosmetic, pharmaceutical and medical applications due to their beneficial properties, ease of application and enhanced patients’ acceptability/compliance. Below the recent developments of topical foams for cosmetic and dermal applications are reviewed, classification based on foam formulation is provided and recent assessment methods of important physical parameters of topical foam are reviewed. In spite of the increasing number of studies devoted to topical foams for dermal applications, the majority of studies have assessed the stability and structure of foam in contact with solid nonporous surfaces. Improved understanding of the destabilisation mechanisms of such foams in contact with porous surfaces, such as skin or skin-like membranes still remains elusive. The review ends with recent developments in dermal foams; considerable attention has been paid in developing novel foams for the treatment of chronic skin diseases and disorders, particularly those involving skin infections.

Introduction

The skin covers the entire human body and plays a crucial role in synthesising vitamin D, regulating the body temperature, and protecting the body from external factors such as infectious agents, water loss, chemical and toxic contaminants [1]. High exposure to various environmental stresses and many other external factors make the skin susceptible to diverse diseases and disorders [1]. On the other hand, the outmost layer of the epidermis of skin, known as stratum corneum, is the major penetration route for topical drug delivery [2]. The stratum corneum is of great interest for both cosmetic and pharmaceutical industries as it acts as the first layer of penetration for topical drug delivery and protection against the outside environment [3,4].

Topical therapy is the cornerstone of the dermatological field. The studies on topical products is rapidly increasing in number due to the fast-growing demand for their applications in healthcare technologies, cosmetic and pharmaceutical industries. Particularly over the past decade, the study of topical foam technology has received considerable attention from the scientific community because of their advantages over conventional topical formulations such as solutions, creams, gels, lotions, emollients and ointments [3,5,6].

Foam formulations are easier to spread uniformly over the skin surface and allows better coverage of the contact area [3,5,6]. In addition, foams easily reach difficult to access skin areas including wrinkles, skin folds, etc [3,5]. In cases of hirsute skin areas, foams show rapid breakdown and access to the stratum corneum through hair shafts [5]. Foams are particularly useful for application on highly inflamed, swollen, abraded, infected and sensitive skin (e.g. for the treatment of psoriasis, sunburn, eczema, seborrheic, acne) [3,5, 6, 7]. Foam applications minimise the need for touching and rubbing onto the skin as foams spread readily on the skin with negligible or mild mechanical shear forces [3,5,6]. This advantage makes them superior to traditional dosage forms that require rubbing and hence cause more pain, inflammation, and irritation [3,5]. Depending on the formulation ingredients, foams can offer drying [3], cooling [8], soothing [7,9], emollient or moisturising effects to the skin [7]. Foam is less dense and less sticky compared to conventional dosage forms [3,5,10]. Foam vehicles are capable of delivering an accurate dose [3,7]. Foams do not drip off the skin and leave low levels of residues, thereby minimising staining of the body and clothes [3,7,11]. As foam formulations are kept in a sealed canister, their contamination potential is minimised. During the past two decades, there has been a growing interest amongst researchers in the development of foams to facilitate and/or enhance topical drug delivery [3,5, 6, 7,10,12,13]. Surveys of patients’ opinions on the usability of foams shows excellent patient compliance/acceptability and a significant preference for foams over conventional topical vehicles [7,14, 15, 16, 17]. Quantitative assessments of topical vehicles by 20 patients diagnosed with psoriasis showed a significant preference for foam over cream, emollient, gel and ointment [14]. Similarly, a study of 279 patients with mild to moderate plaque-type psoriasis showed that use of foam formulations resulted in enhanced patient compliance/acceptability over conventional formulations (i.e. creams) [16]. Foam formulations were shown to result in increased drug versatility and patient tolerability in the treatment of steroid-responsive dermatoses [15].

Despite the aforementioned advantages of foams (i.e. sterility, ease of application), the number of topical foam products available in the market are rather lower compared with traditional products (i.e. creams, gels) [3]. Semisolid dosage forms (e.g. creams, gels, lotions, ointments) are the most commonly used topical vehicles [1]. Foam dosing systems (e.g. pressurised aerosol foams) can be more expensive and complex as they are dependent on propellant technology [5]. One of the main concerns regarding aerosol foams is the adverse environmental effects of propellants used for foam production (i.e. ozone layer depletion).

Although topical foams have considerable potential for healthcare applications (i.e. cosmetic, pharmaceutical), only a small number of studies have taken full advantage of nature of foams [3]. This work presents a review of recent studies related to topical foams for cosmetic and dermal applications. Firstly, the main components of foam formulation are introduced and explained. Commercially available topical foams are classified, and their key attributes are provided. The most commonly used methods to determine topical foam stability and structure are explained and discussed. Recent literature related to the permeation and absorption of topical foam formulation through skin is reviewed. Finally, recent developments of topical foams for dermal applications are summarised and the potential of topical foam in treating bacterial skin infection is highlighted.

Section snippets

Foam formulation

Liquid foam formulations depend on the dispersion of a high concentration of gas bubbles in a small amount of a continuous liquid phase containing foaming agents (i.e. surfactants). Topical foams contain different components which are usually surface-active agents, stabilisers, solvents, active pharmaceutical ingredients and/or active cosmetic ingredients, and may also include other excipients (i.e. preservatives, penetration enhancers). The basis for selection of these components for the

Current developments and applications of topical foams on skin

In this section, the focus is on topical foams that are intended to be applied on human skin for cosmetic and pharmaceutical purposes using ACIs and APIs, respectively. Depending on foam formulations and foaming method, the properties and characteristics of foam such as stability, drainage, carrying capability of AIs, structure, and volume can be different. These characteristics and properties of foam are essential in the enhanced application of cosmetic products, e.g., shaving foam and shampoo

Conclusions

This review clearly shows the increasing interest in the use of topical foams for both cosmetic and pharmaceutical applications. The main components of foam formulation and commonly used topical foam classes were introduced and explained. A review of experimental methods for the measurement of important physical properties of foams revealed that most recent studies did not study foam stability and structure on a skin-like porous substrate. The porous structure may lead to significant changes in

Author contributions

M. P. wrote the original draft of the manuscript. M. P. edited the original manuscript and prepared the final version of the manuscript with support from A. T., D. M., and V. S.; All authors have given approval to the final version of the manuscript.

Conflict of interest statement

None declared.

Acknowledgments

M. P. was supported by the Doctoral Prize Fellowship from Loughborough University, UK. V. S. and A. T. were supported by the MAP EVAPORATION project and European Space Agency.

References (53)

  • Friedman D, Besonov A, Tamarkin D, Eini M. Antibiotic kit and composition and uses thereof. US 2019/0076451 A1,...
  • U. Mrowietz et al.

    A phase II, randomized, double-blind clinical study evaluating the safety, tolerability, and efficacy of a topical minocycline foam, FMX103, for the treatment of facial papulopustular rosacea

    Am J Clin Dermatol

    (2018)
  • T. Williamson et al.

    Concerns and treatment satisfaction in patients being treated with azelaic acid foam for rosacea

    J Drugs Dermatol JDD

    (2019)
  • R.-K. Chang et al.

    Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products

    AAPS J

    (2013)
  • A. Pouillot et al.
    (2008)
  • C.H. Purdon et al.

    Foam drug delivery in dermatology

    Am J Drug Deliv

    (2003)
  • Y. Zhao et al.

    Dynamic foams in topical drug delivery

    J Pharm Pharmacol

    (2010)
  • D. Tamarkin et al.

    Emollient foam in topical drug delivery

    Expert Opin Drug Deliv

    (2006)
  • Riedel H, Schulz J, Goppel A, Bleckmann A. Self-foaming, foam-like, after-foaming or foamable cosmetic or...
  • Tamarkin D, Eini M, Friedman D, Zlatkis E, Schuz D, Berman T. Sensation modifying topical composition foam. US...
  • Eini M, Tamarkin D. Pharmaceutical and cosmetic carrier and composition for topical application. US 6,994,863 B2,...
  • C. Aguzzi et al.

    Penetration and distribution of thiocolchicoside through human skin: comparison between a commercial foam (Miotens®) and a drug solution

    AAPS PharmSciTech

    (2008)
  • T.S. Housman et al.

    Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference

    Ther Clin

    (2002)
  • N.R. Kahanek et al.

    Drug Evaluation Desonide: a review of formulations, efficacy and safety

    Expert Opin Investig Drugs

    (2008)
  • A.B. Gottlieb et al.

    The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions

    J Cutan Med Surg

    (2003)
  • K. Cash et al.

    The vehicle found in ketoconazole foam 2% is preferred by patients with mild to severe seborrheic dermatitis over other vehicles, regardless of gender, age, or ethnicity

    J Am Acad Dermatol

    (2008)
  • Cited by (36)

    • Rheology of oil-based nitrogen foam at shallow reservoir conditions: Experiment and evaluation

      2023, Fuel
      Citation Excerpt :

      Currently, foam fluids have been widely applied in many fields, such as petroleum, construction, medicine, chemistry, and fire protection [1–5].

    View all citing articles on Scopus
    View full text